Moulton-backed Redx seeks £80m IPO
Redx, a Liverpool-based biotech company backed by Better Capital boss Jon Moulton, is planning to secure a stock market listing that will value the company at £80m (€102.3m).
The
Redx, a Liverpool-based biotech company backed by Better Capital boss Jon Moulton, is planning to secure a stock market listing that will value the company at £80m (€102.3m).
The